Search Results
Results found for "Novo Nordisk Foundation"
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
Maria Majellaro shares her journey to founding Celtarys in "From Lab to Leadership". Story Behind Celtarys – From Chemistry to Company How does a medicinal chemist become a biotech founder Maria Majellaro’s path from lab research to co-founding Celtarys, as told in her recent Dr.
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
Yamina Berchiche, Founder of Dr. GPCR.
- Accelerating GPCR Drug Discovery
In every role and sector, I found myself drawn to the same critical challenges: missed opportunities, GPCR As the co-founder of Dr.
- 📰 GPCR Weekly News, February 19 to 25, 2024
GPCR Founder Dr. Yamina Berchiche at the 3rd GPCRs Summit in Boston on March 5-7, 2024. Dr. GPCR Founder Dr.
- From GPCR Data Chaos to Decisive Action
Real-Time Global Insight As founder of Dr.
- Adhesion GPCR Consortium Newsletter - May 2024
shocked that I wasn’t asked if I was a student or a PI, I was more proud to say that I was coming as the founder I, in turn, recruited Yamina Berchiche, founder of DrGPCR.com, to join me in this endeavor.
- Molecular creativity in drug discovery
Highlights: • The Foundry Arrives : R&D meets biotech with real-world acceleration, strategic consulting
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
No substantial differences were found between them and the reporter. Figure 4. and Treatment of Dopaminergic Augmentation: A Combined Task Force of the IRLSSG, EURLSSG, and the RLS-Foundation
- 📰 GPCR Weekly News, July 3 to 9, 2023
Trial Assessing GTAEXS617 in Advanced Solid Tumours A Conversation with Murat Tunaboylu, Antiverse Co-Founder
- 📰 GPCR Weekly News, May 15 to 21, 2023
Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew Hopkins, Exscientia’s founder
- 📰 GPCR Weekly News, June 5 to 11, 2023
Our founder Dr. Yamina A.
- 📰 GPCR Weekly News, March 6 to 12, 2023
Fast Company has named Exscientia as one of the Most Innovative Companies of 2023 Dirk Loeffert CEO & Founder
- 📰 GPCR Weekly News, September 4 to 10, 2023
Yamina Berchiche, Founder and Director of Dr.
- 📰 GPCR Weekly News, May 8 to 14, 2023
Achievement in Collaboration to Enable DEL for Membrane Proteins Professor Andrew Hopkins, Exscientia’s founder
- 📰 GPCR Weekly News, February 5 to 11, 2024
April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join our Founder Dr.
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Inversago Pharma’s INV-347 improves metabolic dysfunction in obese mice Aneesh Karatt Vellatt (CSO & Co-Founder Supplier at Prendio Crinetics Pharmaceuticals announces executive departure Call for GPCR Papers Deadline: Nov
- 📰 GPCR Weekly News, February 12 to 18, 2024
GPCR founder Dr.
- 📰 GPCR Weekly News, June 17 to 23, 2024
pyroglutamylated RF-amide peptide QRFP receptor GPR103 Industry News EY Announces Scott Struthers, Ph.D., CEO and Founder
- 📰 GPCR Weekly News, May 29 to June 4, 2023
Yamina Berchiche, our founder.
